Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

To diagnose hair loss, use a systematic approach including history, exams, and tests.

Women with PCOS are more likely to suffer from depression, anxiety, and stress.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

Many COVID-19 survivors experience long-term symptoms like fatigue and sleep issues, needing ongoing medical support.

Doctors need to be better prepared to assess and treat obesity in patients.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Tralokinumab for atopic dermatitis may cause side effects like dizziness, headache, nausea, hair loss, and acne.

Adults with certain skin conditions may have higher levels of inflammation in their body.

Consider benefits and risks of new alopecia treatments for safety.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

Quick treatment of hair disorders in teenage girls is important because of the emotional effects.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The document concludes that careful surgical methods and choosing the right materials are key for successful scalp, skull, and frontal sinus reconstruction.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Caffeine boosts alertness, helps breathing, acts as a diuretic, and may aid cancer treatment.

Finasteride raises suicide-linked aggression and stops clozapine's positive effects in schizophrenia animals.

Some psychoactive drugs can cause skin reactions, with carbamazepine having a higher risk, and stopping the drug and seeing a dermatologist is important.

People with Down syndrome often have skin issues and need regular check-ups for early treatment.

The critique suggests that Wilton's work unintentionally supports the very stereotypes it aims to question and calls for a broader, more inclusive approach to understanding gender.